News

EMA Recommends First Bispecific T-Cell Engager for Relapsed Small Cell Lung Cancer

EMA · oncology - small cell lung cancer · 3 min

EMA Advances Virtual Control Groups to Reduce Animal Testing in Drug Development

EMA · 2 min

AI in European Pharmaceutical R&D: Investment & Regulatory Insights

EMA · Pharmaceutical R&D · 9 min

EMA Accelerated Assessment of Novel mRNA Vaccine Platforms for Pandemic Preparedness

EMA · Infectious diseases · 9 min

Gene Therapies for Neurological Disorders: EMA Approval Trends & Insights

EMA · Neurology · 8 min

EU Clinical Trials Regulation 2026: Impact on Rare Disease Drug Development

EMA · rare diseases · 5 min

Blockchain in Pharmaceutical Supply Chain: EMA's Role in Traceability & Anti-Counterfeiting

EMA · Pharmaceutical Supply Chain Security · 11 min

GDPR Impact on Pharmaceutical Data: What You Need to Know

EMA · 14 min

AI-Powered Clinical Trial Matching: Transforming Patient Recruitment in the EU

EMA · clinical trials · 11 min

Digital Therapeutics in Europe: Market Trends and EMA Regulatory Insights

EMA · Digital Therapeutics · 11 min

MHRA post-Brexit regulatory pathway vs EMA: Strategic Guide 2024

MHRA, EMA · 12 min

Orphan Drug Pricing EU: Market Analysis and Reimbursement Trends

EMA · rare diseases · 10 min